| Closed |
SWOG-9451 |
Resectable Head and Neck |
4/12/1996 |
12/1/2001 |
87% |
|
Published
|
| Closed |
S9635 |
COLORECTAL |
4/1/1998 |
9/15/2000 |
49% |
|
Published
|
| Closed |
S9700 |
PANCREAS |
9/15/1997 |
6/19/2001 |
90% |
|
Published
|
| Closed |
S9709 |
Supraglottic Larynx |
9/15/1997 |
12/1/2001 |
65% |
|
Published
|
| Closed |
S9717 |
CERVICAL |
8/15/1998 |
8/15/2000 |
100% |
|
Published
|
| Closed |
S9720 |
ENDOMETRIAL |
2/15/1998 |
7/15/2000 |
100% |
|
Published
|
| Closed |
S9804 |
Advanced Melanoma |
5/15/1999 |
8/1/2001 |
60% |
|
Published
|
| Closed |
S9810 |
Mesothelioma |
2/15/1999 |
8/15/2000 |
100% |
|
Published
|
| Closed |
S9811 |
Hydroxyurea |
11/15/1998 |
6/1/2005 |
66% |
|
Published
|
| Closed |
S9902 |
Recurrent, Refractory or Metastatic |
11/15/1999 |
1/1/2001 |
97% |
|
Published
|
| Closed |
S9912 |
OVARIAN |
10/1/2000 |
8/15/2005 |
100% |
|
Published
|
| Closed |
S9914 |
Chemo in Untreated Extensive SCLC |
10/15/1999 |
6/15/2001 |
99% |
|
Published
|
| Closed |
S0014 |
NON-HODGKIN'S: CHOP with concurrent rituximab plus IFR |
4/1/2000 |
1/15/2002 |
100% |
|
Published
|
| Closed |
SWOG-8207 |
AZQ in Advanced Renal Cell Carcinoma |
7/9/1982 |
3/16/1984 |
|
|
Published
|
| Closed |
SWOG-8038 |
Vinblastine in Advanced Ovarian Cancer |
12/9/1980 |
12/5/1983 |
|
|
Published
|
| Closed |
SWOG-440 |
Bleomycin for Solid Tumors and Lymphomas |
12/11/1970 |
7/1/1971 |
|
|
Published
|
| Closed |
SWOG-8028 |
Evaluation of DHAD in Gynecologic Cancers |
10/20/1980 |
10/3/1984 |
|
|
Published
|
| Closed |
SWOG-8402 |
Evaluation of Esorubicin in Ovarian Cancer |
6/11/1984 |
12/15/1986 |
|
|
Published
|
| Closed |
SWOG-8411 |
Evaluation of DTIC in Metastatic Carcinoid |
7/20/1984 |
2/15/1988 |
|
|
Published
|
| Closed |
SWOG-8725 |
Evaluation of Amonafide in Cervical Cancer |
12/1/1988 |
12/1/1990 |
|
|
Published
|
